On air · 2 of 3 networks
Travere Therapeutics
- travere.com
- US
- 550 employees
Travere Therapeutics’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 20. Watch Travere Therapeutics with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 19 | Checked 30 Oct 2026 | See all 20 ads → | ||
| Meta | Running | 4 | Active ads on the Meta Ad Library, all countries | Checked 27 Oct 2026 | Collect them with the API → |
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 13 Oct 2026 | Collect them with the API → |
Travere Therapeutics has 19 live LinkedIn ads. Its Facebook page had 4 active ads on 27 Oct 2026, and we recorded no Google ads on 13 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 11 Nov 2024
- LINKEDIN · IMAGERecorded 2 Oct 2026
We look forward to presenting 11 abstracts, including a late-breaking poster presentation, on our work in IgA nephropathy and FSGS at the American Society of Nephrology’s Kidney Week 2025. We are committed to making a difference in the lives of people impacted by rare kidney disease (RKD).
- LINKEDIN · FOLLOWRecorded 2 Oct 2026
Get the latest jobs and industry news
- LINKEDIN · CAROUSELRecorded 21 Oct 2026
Scientific progress starts with understanding the most critical signals. At Travere, our researchers study certain biomarkers to deepen our understanding of kidney health and disease progression in rare kidney disease (RKD). Every new insight helps build a clearer understanding of RKD and creates new opportunities to improve the lives of patients and their families.
- LINKEDIN · VIDEORecorded 21 Oct 2026
Sometimes the earliest signals can tell us something important. Proteinuria is one biomarker healthcare professionals may monitor to better understand kidney health and disease progression in people living with rare kidney disease. By continuing to study biomarkers like proteinuria, we can work toward a deeper understanding of rare kidney disease.
- LINKEDIN · VIDEORecorded 21 Oct 2026
For people living with rare kidney disease, every unanswered question represents an opportunity for progress. That's why Travere remains committed to improving patient outcomes by advancing research that helps expand understanding of disease progression and biomarkers.
6 of 20 adsSign up to see every Travere Therapeutics ad, filter by format and date, and get alerts on new ones.
See all 20 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.